Coeptis Therapeutics Holdings, Inc. (COEP)
Apr 24, 2026 - COEP merged into ZSQR
16.40
+0.19 (1.17%)
Inactive · Last trade price on Apr 24, 2026

COEP Ratios and Metrics

Millions USD. Fiscal year is Jan - Dec.
Fiscal Year
CurrentFY 2025 FY 2024 FY 2023 FY 2022 FY 2021 2020 - 2018
Period Ending
Apr '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21 2020 - 2018
Market Capitalization
102761127302,494
Upgrade
Market Cap Growth
193.85%572.97%-57.71%-10.53%-98.80%637.84%
Upgrade
Enterprise Value
96721226262,497
Upgrade
Last Close Price
-14.255.5015.6830.63200.00
Upgrade
PS Ratio
74.8855.83---33258.23
Upgrade
PB Ratio
6.955.412.9232.856.711061.15
Upgrade
P/TBV Ratio
8.076.028.7932.856.711061.15
Upgrade
EV/Sales Ratio
70.7952.53---33296.44
Upgrade
Debt / Equity Ratio
0.020.020.361.500.461.74
Upgrade
Net Debt / Equity Ratio
-0.43-0.430.22-0.30-0.390.81
Upgrade
Net Debt / EBITDA Ratio
0.510.51-0.100.010.05-0.14
Upgrade
Net Debt / FCF Ratio
0.710.71-0.130.030.45-0.42
Upgrade
Asset Turnover
0.110.11---0.02
Upgrade
Quick Ratio
3.603.600.120.511.750.79
Upgrade
Current Ratio
4.164.160.230.591.810.79
Upgrade
Return on Equity (ROE)
-136.91%-136.91%-464.73%-807.49%-1104.48%-
Upgrade
Return on Assets (ROA)
-65.05%-65.05%-93.24%-215.14%-291.15%-248.47%
Upgrade
Return on Capital Employed (ROCE)
-90.70%-90.70%-228.80%-1358.10%-595.40%-351.10%
Upgrade
Earnings Yield
-11.68%-15.66%-94.45%-79.54%-125.73%-0.54%
Upgrade
FCF Yield
-8.43%-11.30%-58.80%-27.08%-12.97%-0.18%
Upgrade
Buyback Yield / Dilution
-120.03%-120.03%-49.84%-79.70%-30.98%-79.11%
Upgrade
Source: S&P Capital IQ. Standard template. Financial Sources.